About this trial
Severe childhood adversity accounts for a large portion of psychiatric illness, and an increased risk for major depressive disorder (MDD). For some individuals, childhood adversity has negative psychological and medical consequences; others preserve mental and physical health despite such experiences (they are resilient). In spite of this, little is known about the neurobiological mechanisms related to childhood adversity, especially oxidative stress abnormalities in the brain. To fill this gap, this study combines functional, structural, and molecular imaging approaches to examine the role of oxidative stress abnormalities related to childhood adversity.
Eligibility criteria
Qualifiers
Females of all races and ethnic origins
Ages from 20 to 32
Right-handed
Capable of providing written informed consent
Disqualifiers
Participants with suicidal ideation where continued study participation is deemed unsafe by the study clinician (these participants will be immediately referred to appropriate clinical treatment)
Pregnant women, or women of childbearing potential who have a positive result on a urine pregnancy test
Failure to meet MRI safety requirements including but not limited to any metal implants or prostheses that cannot be removed, or exposure to shrapnel
Claustrophobia or severe anxiety that might impact participation in neuroimaging
Trial design
Treatments tested in this trial
- Not listed